{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:03:53Z","timestamp":1782842633623,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bioorg.2021.105586","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T03:13:17Z","timestamp":1641438797000},"page":"105586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Click inspired novel pyrazole-triazole-persulfonimide & pyrazole-triazole-aryl derivatives; Design, synthesis, DPP-4 inhibitor with potential anti-diabetic agents"],"prefix":"10.1016","volume":"120","author":[{"given":"Manisha","family":"Nidhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaziya","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Sonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archisman","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaraj","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105586_b0005","doi-asserted-by":"crossref","unstructured":"American diabetes association. Diagnosis and classification of diabetes mellitus. Diabetes care 27 (2004) 5-10. doi: 10.2337\/diacare.27.2007.S5.","DOI":"10.2337\/diacare.27.2007.S5"},{"key":"10.1016\/j.bioorg.2021.105586_b0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2337\/dc09-S062","article-title":"Diagnosis, and classification of diabetes mellitus","volume":"32","author":"American Diabetes","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.bioorg.2021.105586_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5001\/omj.2012.68","article-title":"Type 2 diabetes mellitus: a review of current trends","volume":"27","author":"Olokoba","year":"2012","journal-title":"Oman Med J"},{"key":"10.1016\/j.bioorg.2021.105586_b0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2017.0241","article-title":"Management of type 2 diabetes in 2017: Getting to goal","volume":"317","author":"Reusch","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.bioorg.2021.105586_b0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.04.061","article-title":"Current anti-diabetic agents and their molecular targets: a review","volume":"152","author":"Kerru","year":"2018","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0030","doi-asserted-by":"crossref","unstructured":"Sebokova, Elena Christ, Andreas Boehringer, Markus Mizrahi, Jacques. Dipeptidyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type 2 diabetes Curr. Topics in Medi. Chem. 7 (2007) 547-555. doi: 10.2174\/ 156802607 780091019.","DOI":"10.2174\/156802607780091019"},{"key":"10.1016\/j.bioorg.2021.105586_b0035","unstructured":"https:\/\/www.diabetes.co.uk\/features\/diabetes-medication-side-effects.html."},{"key":"10.1016\/j.bioorg.2021.105586_b0040","unstructured":"Ganesan K, Rana MBM, Sultan S. 2021 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482386."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105586_b0045","first-page":"146","article-title":"Dipeptidyl Peptidase-4 Inhibitors: a new approach in diabetes treatment","volume":"1","author":"Monika","year":"2009","journal-title":"Int J. Drug Dev. & Res."},{"key":"10.1016\/j.bioorg.2021.105586_b0050","doi-asserted-by":"crossref","unstructured":"Chaudhury Arun, Duvoor Chitharanjan, Reddy Dendi Vijaya Sena, Kraleti Shashank, Chada Aditya, Ravilla Rahul, Marco Asween, Shekhawat Nawal Singh, et. al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management, Frontiers in Endocrinology 8 (2017) 6. https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2017.00006.","DOI":"10.3389\/fendo.2017.00006"},{"key":"10.1016\/j.bioorg.2021.105586_b0055","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.bmcl.2014.03.009","article-title":"Singh Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-4 inhibitors","volume":"24","author":"Jadhav","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105586_b0060","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.bmcl.2011.01.086","article-title":"Discovery of potent dipeptidyl peptidase IV inhibitors derived from \u03b2-aminoamides bearing substituted [1, 2, 3]-triazolopiperidines for the treatment of type 2 diabetes","volume":"21","author":"Shan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105586_b0065","doi-asserted-by":"crossref","unstructured":"Rita Mohan Dallumal, Siew Siang Chua, David Bin-Chia Wu, and Shireene Ratna Vethakkan Sitagliptin: Is It Effective in Routine Clinical Practice, Int. J. Endocrinol. 9 (2015). https:\/\/doi.org\/10.1155\/2015\/950571.","DOI":"10.1155\/2015\/950571"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105586_b0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1358\/dot.2011.47.2.1583163","article-title":"Alogliptin for the treatment of type 2 diabetes","volume":"47","author":"White","year":"2011","journal-title":"Drugs of Today"},{"key":"10.1016\/j.bioorg.2021.105586_b0075","article-title":"Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials","volume":"60603114","author":"Zhong","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bioorg.2021.105586_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109952","article-title":"Trelagliptin succinate: DPP-4 inhibitor to improve insulin resistance in adipocytes","volume":"125","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105586_b0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11164-017-3120-3","article-title":"Facile new industrial process for synthesis of teneligliptin through new intermediates and its optimization with control of impurities","volume":"44","author":"Kumar","year":"2018","journal-title":"Res Chem Intermed"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105586_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s12039-020-1760-0","article-title":"Design, synthesis and biological evaluation of novel 1,2,3-triazole-based xanthine derivatives as DPP-4 inhibitors","volume":"132","author":"Narsimha","year":"2020","journal-title":"J Chem Sci"},{"key":"10.1016\/j.bioorg.2021.105586_b0095","doi-asserted-by":"crossref","first-page":"514519","DOI":"10.1002\/ddr.20278","article-title":"D-420720, A novel orally active sulfonamide compound dipeptidyl peptidase IV inhibitor: structure and activity relationship of arylsulfonamide to dipeptidyl peptidase IV inhibition","volume":"69","author":"Tsai","year":"2008","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2021.105586_b0100","doi-asserted-by":"crossref","first-page":"83438","DOI":"10.1039\/C6RA15948F","article-title":"Sulfonamide-1, 3, 5-triazine\u2013thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4","volume":"6","author":"Gao","year":"2016","journal-title":"RSC Adv."},{"issue":"21","key":"10.1016\/j.bioorg.2021.105586_b0105","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.3390\/molecules25215003","article-title":"Pyrazole incorporated new thiosemicarbazones: design, synthesis and investigation of DPP-4 inhibitory effects","volume":"25","author":"Sever","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2021.105586_b0110","doi-asserted-by":"crossref","first-page":"116354","DOI":"10.1016\/j.bmc.2021.116354","article-title":"A review upon medicinal perspective and designing rationale of DPP-4 inhibitors","volume":"46","author":"Kumar","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105586_b0115","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/bkcs.10828","article-title":"Novel 1,2,3-triazole analogs of sitagliptin as DPP4 inhibitors","volume":"37","author":"Gundeti","year":"2016","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105586_b0120","article-title":"Design and synthesis of pyrazole-3-one derivatives as hypoglycaemic agents","author":"Damavand","year":"2015","journal-title":"Int. J. Med. Chem. b"},{"key":"10.1016\/j.bioorg.2021.105586_b0125","doi-asserted-by":"crossref","first-page":"1035272","DOI":"10.1016\/j.bioorg.2019.103527","article-title":"Design, synthesis, docking and biological evaluation of chalcones as promising anti-diabetic agents","volume":"95","author":"Rammohan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ejmech.2017.10.046","article-title":"Quinoline derivatives bearing pyrazole moiety: synthesis and biological evaluation as possible antibacterial and antifungal agents","volume":"143","author":"El Shehry","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0135","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejmech.2013.03.005","article-title":"Synthesis of novel 1, 3, 4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents","volume":"63","author":"Ragab","year":"2013","journal-title":"Eur J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0140","doi-asserted-by":"crossref","unstructured":"I. Koca, A. \u00d6zg\u00fcr, K.A. Co\u015fkun Y. Tutar, Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety, Bioorg. Med. Chem. 21 (2013) 3859\u20133865, doi: 0.1016\/j.bmc.2013.04.021.","DOI":"10.1016\/j.bmc.2013.04.021"},{"key":"10.1016\/j.bioorg.2021.105586_b0145","doi-asserted-by":"crossref","unstructured":"FaribaPeytam, MehdiAdib, ReihanehShourgeshty, Maryam Mohammadi Khanaposhtani, Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro \u03b1-glucosidase inhibition, kinetic and docking studies Molecular Diversity, 24 (2020) 69\u201380, doi: 10.1007\/s11030-019-09925-8.","DOI":"10.1007\/s11030-019-09925-8"},{"key":"10.1016\/j.bioorg.2021.105586_b0150","doi-asserted-by":"crossref","unstructured":"Fikret Turkan, Adnan Cetin, Parham Taslimi, Muhammet Karaman, \u0130lhami Gul\u00e7in Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorganic Chemistry 86 (2019) 420-427. doi: 10.1016\/j.bioorg.2019.02.013.","DOI":"10.1016\/j.bioorg.2019.02.013"},{"key":"10.1016\/j.bioorg.2021.105586_b0155","doi-asserted-by":"crossref","first-page":"103023","DOI":"10.1016\/j.bioorg.2019.103023","article-title":"Noha Hilmy Elnagdi, Design, synthesis, modeling studies and biological screening of novel pyrazole derivatives as potential analgesic and anti-inflammatory agents","volume":"89","author":"Taher","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2017.11.010","article-title":"Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents","volume":"76","author":"Naim","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0165","first-page":"86","volume":"82","author":"Khaled Abdellatif","year":"2018","journal-title":"El-Magd."},{"issue":"sup1","key":"10.1016\/j.bioorg.2021.105586_b0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/14756366.2016.1180594","article-title":"Khan Synthesis and biological evaluation of fluoropyrazolesulfonylurea and thiourea derivatives as possible anti-diabetic agents","volume":"31","author":"Faidallah","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2021.105586_b0180","doi-asserted-by":"crossref","first-page":"103206","DOI":"10.1016\/j.bioorg.2019.103206","article-title":"Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: design, synthesis, in vitro \u03b1-glucosidase inhibition, kinetic, and docking studies","volume":"92","author":"Asgari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0185","first-page":"12","article-title":"Design, synthesis, biological evaluation, and docking study of new acridine-9-carboxamide linked to 1,2,3-triazole derivatives as antidiabetic agents targeting \u03b1-glucosidase","volume":"57","author":"Mohammad Asgari","year":"2020","journal-title":"J. Hetrocyclic Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0190","doi-asserted-by":"crossref","first-page":"128745","DOI":"10.1016\/j.molstruc.2020.128745","article-title":"Design, synthesis and anti-diabetic activity of novel 1, 2, 3-triazole-5 carboximidamide derivatives as dipeptidyl peptidase-4 inhibitors","volume":"1221","author":"Fasihi Dastjerdi","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2021.105586_b0195","doi-asserted-by":"crossref","unstructured":"Shaziya Khanam, Sunil K. Pandey, Sunil K. Rai, Deepshikha Verma, Jerry P. Jasinski, Seema Pratap, and Ashish K. Tewari Synthesis of N, N-Bis-Sulfonylated and N-Alkyl-N-Sulfonylated G1 Dendrimers via Click Reaction: Application of Thiocarbamide based CuI Catalysts Chemistry Select 2 (2017) 6370 \u2013 6374. doi: 10.1002\/slct.201701591.","DOI":"10.1002\/slct.201701591"},{"key":"10.1016\/j.bioorg.2021.105586_b0200","doi-asserted-by":"crossref","unstructured":"Shaziya Khanam, Sunil K. Rai, Deepshikha Verma, Ranjana S. Khannaa and Ashish K. Tewari, an efficient and controlled synthesis of persulfonylated G1 dendrimers via click reaction RSC Adv., 6 (2016) 56952. doi: 10.1039\/c6ra09929.","DOI":"10.1039\/C6RA09929G"},{"issue":"9","key":"10.1016\/j.bioorg.2021.105586_b0205","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00044-011-9774-2","article-title":"Ashish Kumar Tewari, Synthesis of pyrazole-based 1, 5-diaryl compounds as potent anti-inflammatory agents","volume":"21","author":"Shrivastava","year":"2012","journal-title":"Med Chem Res."},{"key":"10.1016\/j.bioorg.2021.105586_b0210","doi-asserted-by":"crossref","unstructured":"Ashish Kumar Tewari, Ved Prakash Singh, Pratima Yadav, Garima Gupta, Amit Singh, Raj Kumar Goel, Pravin Shinde, C. Gopi Mohan, Synthesis, biological evaluation and molecular modelling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents Bioorganic Chemistry 56 (2014) 8\u201315. http:\/\/dx.doi.org\/10.1016\/j.bioorg.2014. 05.004.","DOI":"10.1016\/j.bioorg.2014.05.004"},{"key":"10.1016\/j.bioorg.2021.105586_b0215","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejmech.2019.05.045","article-title":"Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: \u03b1-Glucosidase inhibition and glucose uptake promotion","volume":"177","author":"Ye","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105586_b0220","doi-asserted-by":"crossref","first-page":"111702","DOI":"10.1016\/j.ejmech.2019.111702","article-title":"Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies","volume":"183","author":"Zengin Kurt","year":"2019","journal-title":"European Journal of Medicinal Chemistry 183"},{"key":"10.1016\/j.bioorg.2021.105586_b0225","doi-asserted-by":"crossref","unstructured":"Hossein Fasihi Dastjerdi, Nima Naderi, Manijeh Nematpour, Elham Rezaee, Mohammad Mahboubi-Rabbani, Melika Ebrahimi, Design, synthesis and anti-diabetic activity of novel 1, 2, 3-triazole-5- carboximidamide derivatives as dipeptidyl peptidase-4 inhibitors. Journal of Molecular Structure 1221 (2020) 128745. doi: 10.1016\/j.molstruc.2020128745.","DOI":"10.1016\/j.molstruc.2020.128745"},{"key":"10.1016\/j.bioorg.2021.105586_b0230","doi-asserted-by":"crossref","unstructured":"Mao-Tsu Fuh, Ching-Chun Tseng, Sin-Min Li, Shuo-En Tsai, Tsung-Jui Chuang, Chih-Hao Lu, Ya-Chen Yang, Henry J. Tsai, Fung Fuh Wong, Design, synthesis and biological evaluation of glycolamide, glycinamide, and \u03b2-amino carbonyl 1,2,4-triazole derivatives as DPP-4 inhibitors. Bioorganic Chemistry 114 (2021) 105049. doi: 10.1016\/j. bioorg.2021.105049.","DOI":"10.1016\/j.bioorg.2021.105049"},{"key":"10.1016\/j.bioorg.2021.105586_b0235","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bioorg.2018.09.021","article-title":"Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabelling and bio distribution studies","volume":"81","author":"Somaia Abd El-Karim","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105586_b0240","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.bmcl.2018.05.022","article-title":"Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors","volume":"28","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105586_b0245","doi-asserted-by":"crossref","unstructured":"Bhumika D. Patel a, Shraddha V. Bhadada b, Manjunath D. Ghate a Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 inhibitors, Bioorganic Chemistry 72 (2017) 345\u2013358. http:\/\/dx.doi.org\/10.1016\/j.bioorg. 2017.03.004.","DOI":"10.1016\/j.bioorg.2017.03.004"},{"key":"10.1016\/j.bioorg.2021.105586_b0250","doi-asserted-by":"crossref","unstructured":"Fida Hussaina, Zeeshan Khan, Muhammad Saeed Jana, Sajjad Ahmada, Ashfaq Ahmad, Synthesis, in-vitro \u03b1-glucosidase inhibition, antioxidant, in-vivo anti-diabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives. Bioorganic Chemistry. 91 (2019) 103128. doi: 10.1016\/j.bioorg.2019.103128.","DOI":"10.1016\/j.bioorg.2019.103128"},{"key":"10.1016\/j.bioorg.2021.105586_b0255","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.bmcl.2007.01.111","article-title":"Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors","volume":"17","author":"Ahn","year":"2007","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bioorg.2021.105586_b0260","article-title":"Crystal structure of DPP-8 in complex with a 4-oxo-b-lactam based inhibitor","author":"Ross","year":"2020","journal-title":"A272"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821009640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821009640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:23:27Z","timestamp":1758615807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821009640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":52,"alternative-id":["S0045206821009640"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105586","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Click inspired novel pyrazole-triazole-persulfonimide & pyrazole-triazole-aryl derivatives; Design, synthesis, DPP-4 inhibitor with potential anti-diabetic agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105586"}}